GlaxoSmithKline Pakistan Limited (PSX: GLAXO)

GlaxoSmithKline Pakistan Ratios and Metrics

Market cap in millions PKR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 28, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	131,887	26,430	27,952	43,474	61,092	51,136
Market Cap Growth	160.02%	-5.45%	-35.70%	-28.84%	19.47%	42.50%
Enterprise Value	125,362	22,631	20,591	38,013	57,102	50,853
Last Close Price	414.13	82.99	87.77	129.72	174.89	141.47
PE Ratio	29.26	49.50	11.35	8.12	18.10	16.81
PS Ratio	2.35	0.53	0.67	1.19	1.74	1.40
PB Ratio	5.22	1.22	1.33	2.07	3.50	3.17
P/TBV Ratio	2.52	1.28	1.39	2.17	3.71	3.39
P/FCF Ratio	30.76	-	-	11.80	13.15	41.83
P/OCF Ratio	9.43	16.57	-	8.72	10.25	19.93
EV/Sales Ratio	2.23	0.46	0.49	1.04	1.63	1.39
EV/EBITDA Ratio	15.05	7.85	3.48	4.98	10.09	9.07
EV/EBIT Ratio	17.31	11.52	4.06	5.53	11.63	10.57
EV/FCF Ratio	29.24	-	-	10.32	12.30	41.60
Debt / Equity Ratio	0.01	0.03	0.02	0.01	0.02	0.00
Debt / EBITDA Ratio	0.02	0.25	0.06	0.04	0.07	0.01
Debt / FCF Ratio	0.04	-	-	0.08	0.08	0.04
Asset Turnover	1.30	1.35	1.27	1.30	1.42	1.61
Inventory Turnover	3.12	4.30	4.20	4.24	4.48	4.62
Quick Ratio	0.82	0.83	0.92	1.40	1.13	0.80
Current Ratio	1.68	1.74	1.82	2.28	2.04	2.04
Return on Equity (ROE)	19.63%	2.50%	11.72%	27.84%	20.08%	19.27%
Return on Assets (ROA)	10.48%	3.33%	9.60%	15.20%	12.45%	13.24%
Return on Capital (ROIC)	19.63%	5.61%	14.85%	21.96%	18.03%	19.02%
Return on Capital Employed (ROCE)	26.62%	8.34%	22.39%	31.07%	26.26%	28.21%
Earnings Yield	3.42%	2.02%	8.81%	12.32%	5.52%	5.95%
FCF Yield	3.25%	-0.21%	-16.79%	8.47%	7.60%	2.39%
Dividend Yield	0.00%	-	-	5.40%	3.72%	4.24%
Payout Ratio	40.90%	345.56%	15.23%	38.51%	56.04%	72.99%
Total Shareholder Return	-	-	5.40%	3.72%	4.24%

Source: S&P Capital IQ. Standard template. Financial Sources.